For the year ending 2025-12-31, ZVRA made $106,470K in revenue. $83,229K in net income. Net profit margin of 78.17%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenue, net | 106,470 | |||
| Cost of product revenue (excluding x and x in intangible asset amortization for the years ended xxx xx, 20xx, and 20xx, respectively, shown separately below) | 16,482 | |||
| Intangible asset amortization | 3,862 | |||
| Impairment of intangible assets | 58,710 | |||
| Research and development | 12,743 | |||
| Selling, general and administrative | 77,616 | |||
| Total operating expenses | 90,359 | |||
| Loss from operations | -62,943 | |||
| Gain on sale of prv | 148,325 | |||
| Interest expense | 7,977 | |||
| Fair value adjustment related to warrant and cvr liability | -2,178 | |||
| Fair value adjustment related to investments | -149 | |||
| Interest and other income, net | 6,946 | |||
| Total other income (expense) | 149,621 | |||
| Income (loss) before income taxes | 86,678 | |||
| Income tax expense | 3,449 | |||
| Net income (loss) | 83,229 | |||
| Basic EPS | 1.4 | |||
| Diluted EPS | 1.35 | |||
| Basic Average Shares | 55,311,308 | |||
| Diluted Average Shares | 57,262,715 | |||
ZEVRA THERAPEUTICS, INC. (ZVRA)
ZEVRA THERAPEUTICS, INC. (ZVRA)